Advertisement

Obesity and Kidney Cancer

  • Kathryn M. Wilson
  • Eunyoung ChoEmail author
Chapter
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 208)

Abstract

Renal cell cancer (RCC) is the major type of kidney cancer with increasing incidence. Obesity is one of the well-established risk factors for RCC. Meta-analyses including multiple cohort and case–control studies have found a consistent positive association between obesity and RCC. The association appeared to be independent of other RCC risk factors including hypertension and has been often stronger in women, although a positive association has also been observed in men. Obesity has been largely measured as body mass index (BMI). Studies which evaluated other measures of obesity including waist circumference (WC), waist-to-hip ratio (WHR) as well as increase in weight have reported similar positive associations with RCC. Although the mechanisms by which obesity influences renal carcinogenesis have been under-explored, insulin resistance and certain growth factors including insulin-like growth factor (IGF-1), sex steroid hormones, and biochemical markers such as adiponectin may be involved. The positive association with obesity has been observed with the clear cell type of RCC, which is the major histological subtype. On the other hand, the association between obesity and RCC survival appears to be much more complex. An apparent inverse association between obesity at time of diagnosis and RCC survival has been observed in some studies‚ generating speculation of an “obesity paradox” hypothesis. However, this “paradox” may be due to reverse causation, selection bias, or other forms of bias rather than a true biological association.

Keywords

Obesity BMI Renal cell carcinoma Cancer survival Obesity paradox 

References

  1. 1.
    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi: 10.1002/ijc.29210 CrossRefPubMedGoogle Scholar
  2. 2.
    Muglia VF, Prando A (2015) Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras 48(3):166–174. doi: 10.1590/0100-3984.2013.1927 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Chow WH, Devesa SS (2008) Contemporary epidemiology of renal cell cancer. Cancer J 14(5):288–301. doi: 10.1097/PPO.0b013e3181867628 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Hock LM, Lynch J, Balaji KC (2002) Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 167(1):57–60CrossRefPubMedGoogle Scholar
  5. 5.
    Capitanio U, Montorsi F (2015) Renal cancer. Lancet. doi: 10.1016/S0140-6736(15)00046-X PubMedGoogle Scholar
  6. 6.
    Cho E, Adami HO, Lindblad P (2011) Epidemiology of renal cell cancer. Hematol Oncol Clin North Am 25(4):651–665. doi: 10.1016/j.hoc.2011.04.002 CrossRefPubMedGoogle Scholar
  7. 7.
    Lucca I, Klatte T, Fajkovic H, de Martino M, Shariat SF (2015) Gender differences in incidence and outcomes of urothelial and kidney cancer. Nat Rev Urol 12(10):585–592. doi: 10.1038/nrurol.2015.232 CrossRefPubMedGoogle Scholar
  8. 8.
    Bergstrom A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A (2001) Obesity and renal cell cancer—a quantitative review. Br J Cancer 85(7):984–990CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev 4(8):579–591. doi: 10.1038/nrc1408 CrossRefGoogle Scholar
  10. 10.
    Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR (2012) Association of weight status with mortality in adults with incident diabetes. JAMA 308(6):581–590. doi: 10.1001/jama.2012.9282 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A, Meta-analysis Global Group in Chronic Heart F (2014) The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 38(8):1110–1114. doi: 10.1038/ijo.2013.203
  12. 12.
    Wang F, Xu Y (2014) Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. Int J Cancer 135(7):1673–1686. doi: 10.1002/ijc.28813 CrossRefPubMedGoogle Scholar
  13. 13.
    Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK (2005) Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 93(9):1062–1067. doi: 10.1038/sj.bjc.6602819 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr (2006) Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17(7):901–909. doi: 10.1007/s10552-006-0023-9 CrossRefPubMedGoogle Scholar
  15. 15.
    Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y, Suzuki Y, Ohmori K, Nishino Y, Tsuji I (2005) Obesity and risk of cancer in Japan. Int J Cancer 113(1):148–157. doi: 10.1002/ijc.20529 CrossRefPubMedGoogle Scholar
  16. 16.
    Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomark Prev 6(11):863–873Google Scholar
  17. 17.
    Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578. doi: 10.1016/S0140-6736(08)60269-X CrossRefPubMedGoogle Scholar
  18. 18.
    International WCRF (2015) Continuous update project. Diet, nutrition, physical activity and kidney cancerGoogle Scholar
  19. 19.
    Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, Buchan I (2010) Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 126(3):692–702. doi: 10.1002/ijc.24803 CrossRefPubMedGoogle Scholar
  20. 20.
    Nicodemus KK, Sweeney C, Folsom AR (2004) Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer 108(1):115–121. doi: 10.1002/ijc.11532 CrossRefPubMedGoogle Scholar
  21. 21.
    Pischon T, Lahmann PH, Boeing H, Tjonneland A, Halkjaer J, Overvad K, Klipstein-Grobusch K, Linseisen J, Becker N, Trichopoulou A, Benetou V, Trichopoulos D, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Monninkhof E, Peeters PH, Bueno-de-Mesquita HB, Buchner FL, Ljungberg B, Hallmans G, Berglund G, Gonzalez CA, Dorronsoro M, Gurrea AB, Navarro C, Martinez C, Quiros JR, Roddam A, Allen N, Bingham S, Khaw KT, Kaaks R, Norat T, Slimani N, Riboli E (2005) Body size and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition (EPIC). Int J CancerGoogle Scholar
  22. 22.
    Adams KF, Leitzmann MF, Albanes D, Kipnis V, Moore SC, Schatzkin A, Chow WH (2008) Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol. doi: 10.1093/aje/kwn122 (kwn122 [pii])
  23. 23.
    Luo J, Margolis KL, Adami HO, Lopez AM, Lessin L, Ye W, Women’s Health Initiative I (2007) Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women’s health initiative (United States). Am J Epidemiol 166(7):752–759. doi: 10.1093/aje/kwm137 CrossRefPubMedGoogle Scholar
  24. 24.
    Hughes LA, Schouten LJ, Goldbohm RA, van den Brandt PA, Weijenberg MP (2009) Self-reported clothing size as a proxy measure for body size. Epidemiology 20(5):673–676. doi: 10.1097/EDE.0b013e3181a66eb5 CrossRefPubMedGoogle Scholar
  25. 25.
    Norat T, Aune D, Chan D, Romaguera D (2014) Fruits and vegetables: updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention. Cancer Treat Res 159:35–50. doi: 10.1007/978-3-642-38007-5_3 CrossRefPubMedGoogle Scholar
  26. 26.
    Lindblad P, Wolk A, Bergstrom R, Persson I, Adami HO (1994) The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomark Prev 3(8):631–639Google Scholar
  27. 27.
    Mellemgaard A, Lindblad P, Schlehofer B, Bergstrom R, Mandel JS, McCredie M, McLaughlin JK, Niwa S, Odaka N, Pommer W et al (1995) International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines. Int J Cancer 60(3):350–354CrossRefPubMedGoogle Scholar
  28. 28.
    Linehan WM, Ricketts CJ (2013) The metabolic basis of kidney cancer. Semin Cancer Biol 23(1):46–55. doi: 10.1016/j.semcancer.2012.06.002 CrossRefPubMedGoogle Scholar
  29. 29.
    Solarek W, Czarnecka AM, Escudier B, Bielecka ZF, Lian F, Szczylik C (2015) Insulin and IGFs in renal cancer risk and progression. Endocr Relat Cancer 22(5):R253–R264. doi: 10.1530/ERC-15-0135 CrossRefPubMedGoogle Scholar
  30. 30.
    Datta K, Nambudripad R, Pal S, Zhou M, Cohen HT, Mukhopadhyay D (2000) Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer. J Biol Chem 275(27):20700–20706. doi: 10.1074/jbc.M909970199 CrossRefPubMedGoogle Scholar
  31. 31.
    Spyridopoulos TN, Petridou ET, Skalkidou A, Dessypris N, Chrousos GP, Mantzoros CS, Obesity, Cancer Oncology G (2007) Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer 120(7):1573–1578. doi: 10.1002/ijc.22526
  32. 32.
    Liao LM, Schwartz K, Pollak M, Graubard BI, Li Z, Ruterbusch J, Rothman N, Davis F, Wacholder S, Colt J, Chow WH, Purdue MP (2013) Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity (Silver Spring) 21(7):1478–1485. doi: 10.1002/oby.20138 CrossRefGoogle Scholar
  33. 33.
    Liao LM, Weinstein SJ, Pollak M, Li Z, Virtamo J, Albanes D, Chow WH, Purdue MP (2013) Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Carcinogenesis 34(1):109–112. doi: 10.1093/carcin/bgs322 CrossRefPubMedGoogle Scholar
  34. 34.
    Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH (2013) An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer 132(11):2640–2647. doi: 10.1002/ijc.27934 CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Dal Maso L, Zucchetto A, Tavani A, Montella M, Ramazzotti V, Talamini R, Canzonieri V, Garbeglio A, Negri E, Tonini A, La Vecchia C, Franceschi S (2007) Renal cell cancer and body size at different ages: an Italian multicenter case-control study. Am J Epidemiol 166(5):582–591. doi: 10.1093/aje/kwm108 CrossRefPubMedGoogle Scholar
  36. 36.
    Park YH, Lee JK, Kim KM, Kook HR, Lee H, Kim KB, Lee S, Byun SS, Lee SE (2014) Visceral obesity in predicting oncologic outcomes of localized renal cell carcinoma. J Urol 192(4):1043–1049. doi: 10.1016/j.juro.2014.03.107 CrossRefPubMedGoogle Scholar
  37. 37.
    Kaneko G, Miyajima A, Yuge K, Yazawa S, Mizuno R, Kikuchi E, Jinzaki M, Oya M (2015) Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma. Jpn J Clin Oncol 45(2):210–216. doi: 10.1093/jjco/hyu193 CrossRefPubMedGoogle Scholar
  38. 38.
    Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474. doi: 10.1245/s10434-010-0985-4 CrossRefPubMedGoogle Scholar
  39. 39.
    Institute NC SEER cancer statistics factsheets: kidney and renal pelvis cancer. http://seer.cancer.gov/statfacts/html/kidrp.html
  40. 40.
    Novara G, Martignoni G, Artibani W, Ficarra V (2007) Grading systems in renal cell carcinoma. J Urol 177(2):430–436. doi: 10.1016/j.juro.2006.09.034 CrossRefPubMedGoogle Scholar
  41. 41.
    Delahunt B, Egevad L, Samaratunga H, Martignoni G, Nacey JN, Srigley JR (2015) Gleason and Fuhrman no longer make the grade. Histopathology. doi: 10.1111/his.12803 PubMedCentralGoogle Scholar
  42. 42.
    Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML (2006) Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology 68(4):741–746. doi: 10.1016/j.urology.2006.05.024 CrossRefPubMedGoogle Scholar
  43. 43.
    Awakura Y, Nakamura E, Ito N, Yamasaki T, Kamba T, Kamoto T, Ogawa O (2007) Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma. Urology 70(1):50–54. doi: 10.1016/j.urology.2007.03.034 CrossRefPubMedGoogle Scholar
  44. 44.
    Schrader AJ, Rustemeier J, Rustemeier JC, Timmesfeld N, Varga Z, Hegele A, Olbert PJ, Hofmann R (2009) Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma. J Cancer Res Clin Oncol 135(12):1693–1699. doi: 10.1007/s00432-009-0616-2 CrossRefPubMedGoogle Scholar
  45. 45.
    Jeon HG, Jeong IG, Lee JH, Lee CJ, Kwak C, Kim HH, Lee SE, Lee E (2010) Prognostic value of body mass index in Korean patients with renal cell carcinoma. J Urol 183(2):448–454. doi: 10.1016/j.juro.2009.10.004 CrossRefPubMedGoogle Scholar
  46. 46.
    Naya Y, Zenbutsu S, Araki K, Nakamura K, Kobayashi M, Kamijima S, Imamoto T, Nihei N, Suzuki H, Ichikawa T, Igarashi T (2010) Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma. Urol Int 85(1):30–36. doi: 10.1159/000318988 CrossRefPubMedGoogle Scholar
  47. 47.
    Waalkes S, Merseburger AS, Kramer MW, Herrmann TR, Wegener G, Rustemeier J, Hofmann R, Schrader M, Kuczyk MA, Schrader AJ (2010) Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Causes Control 21(11):1905–1910. doi: 10.1007/s10552-010-9618-2 CrossRefPubMedGoogle Scholar
  48. 48.
    Komura K, Inamoto T, Black PC, Koyama K, Katsuoka Y, Watsuji T, Azuma H (2011) Prognostic significance of body mass index in Asian patients with localized renal cell carcinoma. Nutr Cancer 63(6):908–915. doi: 10.1080/01635581.2011.594207 CrossRefPubMedGoogle Scholar
  49. 49.
    Choi Y, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, Adami HO, Lee JE, Lee HM (2013) Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer 132(3):625–634. doi: 10.1002/ijc.27639 CrossRefPubMedGoogle Scholar
  50. 50.
    Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G, Mikklineni N, Fiegoli B, Kim PH, Voss MH, Shen H, Laird PW, Sander C, Reuter VE, Motzer RJ, Hsieh JJ, Russo P (2013) An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst 105(24):1862–1870. doi: 10.1093/jnci/djt310 CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Ohno Y, Nakashima J, Nakagami Y, Satake N, Gondo T, Ohori M, Hatano T, Tachibana M (2013) Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma. Br J Cancer 109(7):1899–1903. doi: 10.1038/bjc.2013.512 CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Lee HW, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG (2015) Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy. Int J Urol 22(5):455–461. doi: 10.1111/iju.12716 CrossRefPubMedGoogle Scholar
  53. 53.
    Mano R, Hakimi AA, Zabor EC, Bury MA, Donati OF, Karlo CA, Bazzi WM, Furberg H, Russo P (2014) Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma. Can Urol Assoc J 8(9–10):E675–E680. doi: 10.5489/cuaj.1979 CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Lee WK, Hong SK, Lee S, Kwak C, Oh JJ, Jeong CW, Kim YJ, Kang SH, Hong SH, Byun SS (2015) Prognostic value of body mass index according to histologic subtype in nonmetastatic renal cell carcinoma: a large cohort analysis. Clin Genitourin Cancer 13(5):461–468. doi: 10.1016/j.clgc.2015.04.012 CrossRefPubMedGoogle Scholar
  55. 55.
    Lajous M, Bijon A, Fagherazzi G, Boutron-Ruault MC, Balkau B, Clavel-Chapelon F, Hernan MA (2014) Body mass index, diabetes, and mortality in French women: explaining away a “paradox”. Epidemiology 25(1):10–14. doi: 10.1097/EDE.0000000000000031 CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Lajous M, Banack HR, Kaufman JS, Hernan MA (2015) Should patients with chronic disease be told to gain weight? The obesity paradox and selection bias. Am J Med 128(4):334–336. doi: 10.1016/j.amjmed.2014.10.043 CrossRefPubMedGoogle Scholar
  57. 57.
    Banack HR, Kaufman JS (2014) The obesity paradox: understanding the effect of obesity on mortality among individuals with cardiovascular disease. Prev Med 62:96–102. doi: 10.1016/j.ypmed.2014.02.003 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of EpidemiologyHarvard T.H. Chan School of Public HealthBostonUSA
  2. 2.Channing Division of Network Medicine, Department of MedicineBrigham and Women’s Hospital, Harvard Medical SchoolBostonUSA
  3. 3.Department of Dermatology, Warren Alpert Medical SchoolBrown UniversityProvidenceUSA
  4. 4.Department of Epidemiology, School of Public HealthBrown UniversityProvidenceUSA

Personalised recommendations